177 related articles for article (PubMed ID: 4202731)
1. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.
Fearon DT; Austen KF; Ruddy S
J Exp Med; 1973 Dec; 138(6):1305-13. PubMed ID: 4202731
[TBL] [Abstract][Full Text] [Related]
2. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
Fearon DT; Austen KF
J Exp Med; 1975 Oct; 142(4):856-63. PubMed ID: 1185108
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
Fearon DT; Austen KF
J Exp Med; 1977 Jul; 146(1):22-33. PubMed ID: 559720
[TBL] [Abstract][Full Text] [Related]
4. Properdin: initiation of alternative complement pathway.
Fearon DT; Austen KF
Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3220-4. PubMed ID: 1059108
[TBL] [Abstract][Full Text] [Related]
5. Initiation of C3 cleavage in the alternative complement pathway.
Fearon DT; Austen KF
J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512
[TBL] [Abstract][Full Text] [Related]
6. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
7. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
Fearon DT; Austen KF
Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1683-7. PubMed ID: 266208
[TBL] [Abstract][Full Text] [Related]
8. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
9. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
10. Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.
Ruddy S; Austen KF; Goetzl EJ
J Clin Invest; 1975 Mar; 55(3):587-92. PubMed ID: 1167871
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Fearon DT
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
[TBL] [Abstract][Full Text] [Related]
12. Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.
Schreiber RD; Medicus RG; Gïtze O; Müller-Eberhard HJ
J Exp Med; 1975 Sep; 142(3):760-72. PubMed ID: 1165475
[TBL] [Abstract][Full Text] [Related]
13. Properdin factor D: characterization of its active site and isolation of the precursor form.
Fearon DT; Austen KF; Ruddy S
J Exp Med; 1974 Feb; 139(2):355-66. PubMed ID: 4855753
[TBL] [Abstract][Full Text] [Related]
14. Binding of activated properdin to untreated erythrocytes: a new function of activated properdin.
Konno T; Hirai H; Tamura N
Immunology; 1978 Feb; 34(2):207-15. PubMed ID: 627406
[TBL] [Abstract][Full Text] [Related]
15. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
16. Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler JM; Daha MR; Austen KF; Fearon DT
Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3268-72. PubMed ID: 1067618
[TBL] [Abstract][Full Text] [Related]
17. Properdin factor D. II. Activation to D by properdin.
Fearon DT; Austen KF; Ruddy S
J Exp Med; 1974 Aug; 140(2):426-36. PubMed ID: 4211020
[TBL] [Abstract][Full Text] [Related]
18. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
Hammer CH; Abramovitz AS; Mayer MM
J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of Guinea pig properidin.
Nicholson A; Austen KF
J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
[TBL] [Abstract][Full Text] [Related]
20. Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.
Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1978 Dec; 148(6):1722-7. PubMed ID: 722244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
